PMC:7074432 / 10646-11487 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"261","span":{"begin":135,"end":146},"obj":"Chemical"},{"id":"262","span":{"begin":153,"end":164},"obj":"Chemical"},{"id":"346","span":{"begin":9,"end":17},"obj":"Species"},{"id":"347","span":{"begin":23,"end":31},"obj":"Species"},{"id":"348","span":{"begin":88,"end":96},"obj":"Species"},{"id":"349","span":{"begin":478,"end":486},"obj":"Species"},{"id":"350","span":{"begin":699,"end":707},"obj":"Species"},{"id":"358","span":{"begin":259,"end":267},"obj":"Species"},{"id":"371","span":{"begin":169,"end":188},"obj":"Chemical"},{"id":"382","span":{"begin":320,"end":339},"obj":"Disease"},{"id":"383","span":{"begin":669,"end":673},"obj":"Disease"},{"id":"384","span":{"begin":693,"end":698},"obj":"Disease"},{"id":"385","span":{"begin":713,"end":719},"obj":"Disease"},{"id":"386","span":{"begin":786,"end":804},"obj":"Disease"},{"id":"387","span":{"begin":816,"end":825},"obj":"Disease"}],"attributes":[{"id":"A261","pred":"tao:has_database_id","subj":"261","obj":"MESH:D053139"},{"id":"A262","pred":"tao:has_database_id","subj":"262","obj":"MESH:D015774"},{"id":"A346","pred":"tao:has_database_id","subj":"346","obj":"Tax:9606"},{"id":"A347","pred":"tao:has_database_id","subj":"347","obj":"Tax:9606"},{"id":"A348","pred":"tao:has_database_id","subj":"348","obj":"Tax:9606"},{"id":"A349","pred":"tao:has_database_id","subj":"349","obj":"Tax:9606"},{"id":"A350","pred":"tao:has_database_id","subj":"350","obj":"Tax:9606"},{"id":"A358","pred":"tao:has_database_id","subj":"358","obj":"Tax:9606"},{"id":"A371","pred":"tao:has_database_id","subj":"371","obj":"MESH:C558899"},{"id":"A382","pred":"tao:has_database_id","subj":"382","obj":"MESH:D001424"},{"id":"A383","pred":"tao:has_database_id","subj":"383","obj":"MESH:D003643"},{"id":"A384","pred":"tao:has_database_id","subj":"384","obj":"MESH:D003643"},{"id":"A385","pred":"tao:has_database_id","subj":"385","obj":"MESH:D003643"},{"id":"A387","pred":"tao:has_database_id","subj":"387","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"[29] 99 patients All patients were treated in isolationAntiviral therapy given to 76% patients (n=75). The antivirals used were oral oseltamivir, i.v. ganciclovir and lopinavir/ritonavir tablets. The duration of antiviral therapy ranged from 3 to 14 days70 patients received antibiotic treatment. In case of secondary bacterial infection, culture and sensitivity were used as a guide for antibiotic therapy. The duration of antibiotic therapy ranged from 3 to 17 days19 (19%) patients were also treated with additional corticosteroids for a duration of 3-15 daysNoninvasive ventilator=13, invasive ventilator=4, ECMO=3, and requirement of RRT=9 Discharged=31% (n=31)Died=11 (11%)Details of death patients:7/11 deaths age \u003e60 yearsLong history of smoking=3MuLBSTA score could predict outcomeLymphopenia=8Bilateral pneumonia=7Hypertension=3"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T43","span":{"begin":320,"end":339},"obj":"Disease"},{"id":"T44","span":{"begin":330,"end":339},"obj":"Disease"},{"id":"T45","span":{"begin":816,"end":825},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0005113"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"[29] 99 patients All patients were treated in isolationAntiviral therapy given to 76% patients (n=75). The antivirals used were oral oseltamivir, i.v. ganciclovir and lopinavir/ritonavir tablets. The duration of antiviral therapy ranged from 3 to 14 days70 patients received antibiotic treatment. In case of secondary bacterial infection, culture and sensitivity were used as a guide for antibiotic therapy. The duration of antibiotic therapy ranged from 3 to 17 days19 (19%) patients were also treated with additional corticosteroids for a duration of 3-15 daysNoninvasive ventilator=13, invasive ventilator=4, ECMO=3, and requirement of RRT=9 Discharged=31% (n=31)Died=11 (11%)Details of death patients:7/11 deaths age \u003e60 yearsLong history of smoking=3MuLBSTA score could predict outcomeLymphopenia=8Bilateral pneumonia=7Hypertension=3"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T47","span":{"begin":378,"end":379},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T48","span":{"begin":541,"end":542},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T49","span":{"begin":674,"end":676},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T50","span":{"begin":678,"end":680},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T51","span":{"begin":710,"end":712},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"[29] 99 patients All patients were treated in isolationAntiviral therapy given to 76% patients (n=75). The antivirals used were oral oseltamivir, i.v. ganciclovir and lopinavir/ritonavir tablets. The duration of antiviral therapy ranged from 3 to 14 days70 patients received antibiotic treatment. In case of secondary bacterial infection, culture and sensitivity were used as a guide for antibiotic therapy. The duration of antibiotic therapy ranged from 3 to 17 days19 (19%) patients were also treated with additional corticosteroids for a duration of 3-15 daysNoninvasive ventilator=13, invasive ventilator=4, ECMO=3, and requirement of RRT=9 Discharged=31% (n=31)Died=11 (11%)Details of death patients:7/11 deaths age \u003e60 yearsLong history of smoking=3MuLBSTA score could predict outcomeLymphopenia=8Bilateral pneumonia=7Hypertension=3"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T105","span":{"begin":109,"end":119},"obj":"Chemical"},{"id":"T106","span":{"begin":135,"end":146},"obj":"Chemical"},{"id":"T107","span":{"begin":153,"end":164},"obj":"Chemical"},{"id":"T108","span":{"begin":169,"end":188},"obj":"Chemical"},{"id":"T109","span":{"begin":169,"end":178},"obj":"Chemical"},{"id":"T110","span":{"begin":179,"end":188},"obj":"Chemical"},{"id":"T111","span":{"begin":214,"end":223},"obj":"Chemical"},{"id":"T112","span":{"begin":277,"end":287},"obj":"Chemical"},{"id":"T113","span":{"begin":390,"end":400},"obj":"Chemical"},{"id":"T114","span":{"begin":426,"end":436},"obj":"Chemical"},{"id":"T115","span":{"begin":521,"end":536},"obj":"Chemical"}],"attributes":[{"id":"A105","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A106","pred":"chebi_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A107","pred":"chebi_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/CHEBI_465284"},{"id":"A108","pred":"chebi_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A109","pred":"chebi_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A110","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A111","pred":"chebi_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A112","pred":"chebi_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"},{"id":"A113","pred":"chebi_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"},{"id":"A114","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"},{"id":"A115","pred":"chebi_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"[29] 99 patients All patients were treated in isolationAntiviral therapy given to 76% patients (n=75). The antivirals used were oral oseltamivir, i.v. ganciclovir and lopinavir/ritonavir tablets. The duration of antiviral therapy ranged from 3 to 14 days70 patients received antibiotic treatment. In case of secondary bacterial infection, culture and sensitivity were used as a guide for antibiotic therapy. The duration of antibiotic therapy ranged from 3 to 17 days19 (19%) patients were also treated with additional corticosteroids for a duration of 3-15 daysNoninvasive ventilator=13, invasive ventilator=4, ECMO=3, and requirement of RRT=9 Discharged=31% (n=31)Died=11 (11%)Details of death patients:7/11 deaths age \u003e60 yearsLong history of smoking=3MuLBSTA score could predict outcomeLymphopenia=8Bilateral pneumonia=7Hypertension=3"}

{"project":"LitCovid-sentences","denotations":[{"id":"T73","span":{"begin":0,"end":104},"obj":"Sentence"},{"id":"T74","span":{"begin":105,"end":197},"obj":"Sentence"},{"id":"T75","span":{"begin":198,"end":298},"obj":"Sentence"},{"id":"T76","span":{"begin":299,"end":409},"obj":"Sentence"},{"id":"T77","span":{"begin":410,"end":841},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"[29] 99 patients All patients were treated in isolationAntiviral therapy given to 76% patients (n=75). The antivirals used were oral oseltamivir, i.v. ganciclovir and lopinavir/ritonavir tablets. The duration of antiviral therapy ranged from 3 to 14 days70 patients received antibiotic treatment. In case of secondary bacterial infection, culture and sensitivity were used as a guide for antibiotic therapy. The duration of antibiotic therapy ranged from 3 to 17 days19 (19%) patients were also treated with additional corticosteroids for a duration of 3-15 daysNoninvasive ventilator=13, invasive ventilator=4, ECMO=3, and requirement of RRT=9 Discharged=31% (n=31)Died=11 (11%)Details of death patients:7/11 deaths age \u003e60 yearsLong history of smoking=3MuLBSTA score could predict outcomeLymphopenia=8Bilateral pneumonia=7Hypertension=3"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T19","span":{"begin":816,"end":825},"obj":"Phenotype"}],"attributes":[{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"[29] 99 patients All patients were treated in isolationAntiviral therapy given to 76% patients (n=75). The antivirals used were oral oseltamivir, i.v. ganciclovir and lopinavir/ritonavir tablets. The duration of antiviral therapy ranged from 3 to 14 days70 patients received antibiotic treatment. In case of secondary bacterial infection, culture and sensitivity were used as a guide for antibiotic therapy. The duration of antibiotic therapy ranged from 3 to 17 days19 (19%) patients were also treated with additional corticosteroids for a duration of 3-15 daysNoninvasive ventilator=13, invasive ventilator=4, ECMO=3, and requirement of RRT=9 Discharged=31% (n=31)Died=11 (11%)Details of death patients:7/11 deaths age \u003e60 yearsLong history of smoking=3MuLBSTA score could predict outcomeLymphopenia=8Bilateral pneumonia=7Hypertension=3"}

{"project":"2_test","denotations":[{"id":"32201439-32007143-47219432","span":{"begin":1,"end":3},"obj":"32007143"},{"id":"T34227","span":{"begin":1,"end":3},"obj":"32007143"}],"text":"[29] 99 patients All patients were treated in isolationAntiviral therapy given to 76% patients (n=75). The antivirals used were oral oseltamivir, i.v. ganciclovir and lopinavir/ritonavir tablets. The duration of antiviral therapy ranged from 3 to 14 days70 patients received antibiotic treatment. In case of secondary bacterial infection, culture and sensitivity were used as a guide for antibiotic therapy. The duration of antibiotic therapy ranged from 3 to 17 days19 (19%) patients were also treated with additional corticosteroids for a duration of 3-15 daysNoninvasive ventilator=13, invasive ventilator=4, ECMO=3, and requirement of RRT=9 Discharged=31% (n=31)Died=11 (11%)Details of death patients:7/11 deaths age \u003e60 yearsLong history of smoking=3MuLBSTA score could predict outcomeLymphopenia=8Bilateral pneumonia=7Hypertension=3"}